Morphological transformation and effect on gap junction intercellular communication in Syrian hamster embryo cells as

E Rivedal1, S O Mikalsen, T Sanner

  • 1Department of Environmental and Occupational Cancer, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310, Oslo, Norway. edgar.rivedal@labmed.uio.no

Insights

Detecting non-genotoxic carcinogens is crucial. This study shows that testing for cell transformation and inhibited communication in hamster cells effectively identifies these difficult-to-detect environmental agents.

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Cell Biology

Background:

  • Many carcinogens do not directly damage DNA, posing detection challenges.
  • Non-genotoxic carcinogens require alternative screening methods beyond mutagenicity tests.
  • Cell transformation and gap junction communication are potential indicators for non-genotoxic carcinogens.

Purpose of the Study:

  • To evaluate the efficacy of in vitro cell transformation and gap junction intercellular communication assays.
  • To screen 13 known or suspected non-genotoxic carcinogens using these endpoints.
  • To determine if these assays can detect environmental agents that don't interact with DNA.

Main Methods:

  • Utilized Syrian hamster embryo cells for in vitro testing.
  • Assessed the induction of morphological cell transformation by chemical compounds.
  • Measured the inhibition of gap junction intercellular communication (GJIC) following compound exposure.

Main Results:

  • Nine out of 13 tested compounds induced morphological transformation.
  • Seven out of 13 compounds inhibited intercellular communication.
  • Twelve of the 13 non-genotoxic carcinogens tested showed positive results in at least one assay.

Conclusions:

  • Combined assays for cell transformation and GJIC are effective for detecting non-genotoxic carcinogens.
  • These methods offer a valuable screening approach for environmental carcinogens lacking mutagenic activity.
  • The study supports the use of these endpoints for identifying chemicals that pose cancer risks through non-DNA-interactive mechanisms.